RecallDepth
Class II Ongoing

Duloxetine Delayed-Release Capsules, USP, 60mg, 1,000-count bottles, Rx Only, Mfr. by: Towa Pharmaceutical Europe, S.L. Martorelles, (Barcelona), Spain, Distributed by: Breckenridge Pharmaceuticals, Inc., Berkeley Heights, NJ 07922. NDC 51991-748-10.

Company
Breckenridge Pharmaceutical, Inc.
Recall Initiated
July 15, 2025
Posted
August 13, 2025
Recall Number
D-0552-2025
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
1,829 60-count bottles
Firm Location
Berkeley Heights, NJ, United States

Reason for Recall

CGMP Deviations: Presence of N-nitroso-duloxetine impurity above safety assessment limit

Distribution

U.S Nationwide

Lot / Code Info

Lot: 230836C, Exp.: 02/28/2026

More recalls by Breckenridge Pharmaceutical, Inc.

View all recalls by this company →

Other recent Class II Drug recalls